Massive Short Squeeze Possible on Human Genome Sciences (HGSI)

Date: 1/25/2012

Massive Short Squeeze Possible on Human Genome Sciences (HGSI). Live "biotechnology" stock alert on HGSI which is currently trading up $.50 at $9.64 on 8,838,771 shares which is above the 3 month avg of 6,606,430. SMF is always shopping for "Bargains in the Biotech Sector" and in this live trading video we'll cover HGSI Human Genome Sciences.

With 82.5% Institutional ownership, 14.4% Insider Ownership, and 20.4% Short Interest. SMF is long some longer term calls on HGSI and we believe it's possiblely a "take over target" or a "short squeeze candidate" based on the retail short interst and the confirmed lows.

HGSI established a 52 week low of 6.53 on 12/21/2011 and we've seen a confirmed bottom on above average volume. Going into 2012, on 1/11/2011 HGSI appeared on the "Largest Nasdaq Short Interest Positions as of Dec. 30" List with 28,772,752 shares short vs 24,314,807 as of 12/15/2011 representing a 17.31% increase over a 2 week period.

Notable volume days above 10M shares traded include

1/09/2012 - 12,016,800
1/11/2012 - 21,476,000
1/12/2012 - 11,562,600
1/17/2012 - 10,218,800
1/18/2012 - 10,821,200

Biotech pipelines for larger names has been drying up and they'll be looking for stocks that invested strongly in R&D like HGSI to compliment their longer term product line.

Link to this page http://www.stockmarketfunding.com, notify us and we will consider your web site to our directory

StockMarketFunding.com, LLC is not a registered broker-dealer, but rather works in coordination with fully licensed broker-dealers, SIPC-insured clearing firms, and private trading firms to provide licensed and non-licensed clients with access to career trading programs and direct access trading capabilities. Our firm and our network affiliates strongly recommend that all clients fully read and acknowledge all SEC risk disclosure statements available on our site and our affiliate broker-dealer websites prior to engaging in any live trading activity, and acquire a solid understanding of the risks inherent in all types of stock and option trading.